Sponsors 2026

BlueOakNx is a Public Benefit Corporation on a mission to provide access to science-based, practitioner-grade nutraceuticals that enable a better quality of life from the inside out. The first product Mitokatylst™ - E is backed by 15 preclinical and clinical studies and 64 peer-reviewed papers. Mitokatlyst™ is the first targeted molecule clinically proven to induce mitochondrial biogenesis and boost cellular energy.

This promotes skeletal muscle strength, supports metabolic function, supports cardiovascular health, and stimulates a healthy inflammatory response. As of September of 2024, 14 more clinical trials and observational studies have been independently initiated at various universities in the US, Scotland, and Sweden. Co-founder Sundeep Dugar, PhD, also leads the $101M XPrize Healthspan Semifinalist team, A New Dimension.

Learn more at www.blueoaknx.com

Secretech Biosciences develops highly multiplexed molecular analysis technologies that preserve molecular context across individual biological structures. Its proprietary Proximity Barcoding Assay (PBA) platform enables scalable protein profiling of individual organelles, extracellular vesicles, protein complexes, and other biological structures, revealing molecular signatures that can deepen our understanding of mitochondrial heterogeneity.

For more information: www.secretech.com

Eos SENOLYTIX is a longevity company using MitoXcel™ Technology to develop novel therapeutics targeting the fundamental mechanisms of aging. Its lead clinical candidates, PTC-2105 and PTC-2107, both proprietary MitoXcel™ geropeptides, have demonstrated the ability to rejuvenate naturally aged mice via two separate mechanisms, both targeting the mitochondrial membrane potential (MMP), also called the “Δψm” (pronounced “delta psi em”), the difference in electrical potential between the mitochondrial matrix and the cytosol generated as protons are pumped out during the process of oxidative phosphorylation, during which the mitochondria “burn” carbohydrates, fats, and proteins, turning them into into ATP molecules, the packets of energy used by cells to fuel all of life’s processes, in the presence of oxygen.

For more information: www.eossenolytix.com

Nanolive is a Swiss biotechnology company at the forefront of label-free live cell data, empowering mitochondrial researchers with a real-time, non-invasive method to study living cells. Its technology eliminates the need for dyes or fluorescent markers, preserving native cellular physiology and enabling long-term monitoring of mitochondrial dynamics.

By combining quantitative image acquisition (dry mass, volume, and refractive index) with the Smart Mitochondrial Assay^LIVE, Nanolive offers the first fully automated, label-free solution to quantify mitochondrial dynamics. This approach allows researchers to monitor mitochondrial health and drug responses without perturbing cell viability or behavior. Integrated with Nanolive’s additional digital analysis solutions for cell viability, phenotype and lipid droplets, comprehensive cell profiling without labels is made possible, enabling more predictive, biologically relevant insights that improve decision-making in mitochondrial research and drug development.

Nanolive is proud to support the 17^th Annual Targeting Mitochondria meeting and the scientific community to advance research on mitochondria.

Learn more at www.nanolive.com

Mitochondrial Research Needs a Shift: From Snapshots to Dynamics

Mitochondrial science is moving toward functional, real-time biology. Tools that capture dynamic cellular behavior are now essential.

Lucid Scientific’s platform, Resipher, enables continuous, non-invasive measurement of oxygen consumption directly inside standard incubators, with longitudinal profiling over hours to days.

Most metabolic assays still rely on static, endpoint measurements. Mitochondria operate dynamically, adapting continuously to stress, drugs, and signaling inputs.

Continuous oxygen consumption monitoring allows:

• Detection of transient metabolic shifts otherwise missed
• Improved reproducibility across experiments
• Refined analysis of drug response kinetics
• More accurate modeling of mitochondrial adaptation

At the Berlin congress, Lucid Scientific will present how real-time bioenergetics can refine mitochondrial phenotyping and accelerate translational workflows.

For more information about Lucid Scientific and the Resipher system :  lucidsci.com.